mRNA technology predates COVID-19 by more than a decade, and a protein-based alternative exists for patients who remain ...

Cox-adjusted analyses associated ≥1 year HRT use with reduced all-cause dementia (HR 0.90) and Alzheimer disease (HR 0.84), ...

The law of rhythm states, simply, that everything moves in a predictable cycle. Day follows night and seasons follow one ...

Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what ...

FDA approved 40-mg and 50-mg BID leniolisib for APDS in children 4–11 years weighing ≥27 kg, representing the first ...

Real-world effectiveness is limited, with 60%–70% not achieving optimal glycemic control after 1 year on GLP-1 therapy, ...

An analysis found all-cause pneumonia Black, lower-income, and medically at-risk children still face substantially higher rates of hospitalization. In this episode, Shawn Bjorndal, PharmD, RPh, and ...

Advanced respiratory support during acute hospitalization demonstrated the strongest pooled association with post-COVID-19 ...

AD109 produced statistically significant AHI improvement versus placebo at 26 weeks (treatment difference –4.0 events/hour; ...

Women showed consistently higher post-T2D mental health diagnoses, with the strongest signal in younger women, supporting ...

A cross-sectional study of 429 adults found that chronic fatigue, cognitive impairment, and menstrual irregularity were the most commonly self-reported long-term adverse effects f ...

From the industry-wide efforts of major players in pharmacy to grassroots efforts at the local level, advocacy for the ...